Partnering Solutions
-
Oncology CRO Services
11/7/2023
Biotechnology companies are facing increased challenges around participant recruitment and retention, lengthy timeframes and relatively high costs.
-
Partnering With Leading Innovator TrakCel To Support CGTs
9/27/2023
Our combined offering aims to increase speed-to-therapy by increasing connectivity between providers and hub patient services.
-
Restoring Business Trust And Confidence In Clinical Trials
5/31/2023
Inspired by excellence and empowered by people, explore how inSeption Group is able to work as a full-service outsourcing solution to meet and exceed study expectations.
-
Optimize Your Endpoint Adjudication On A Single Platform
2/1/2023
Medidata Adjudicate is part of the Medidata Clinical Cloud™, and offers a cloud-based, end-to-end solution, with easily configurable modules enabling quick setup to manage endpoint adjudication in clinical trials. Medidata Adjudicate supports investigator sites, sponsors, CROs, data managers, and the CEC in collecting, managing, organizing, adjudicating and submitting clinical endpoint data.
-
Orphan And Rare Disease CRO Services
11/7/2023
Rare Disease clinical studies demand a specialized full-service CRO with expertise in enrollment, site selection, and global regulatory knowledge, including access to patient registries for accelerated recruitment.
-
Rave TSDV - Improve CRA Efficiency And Reduce Site Burden
12/20/2023
Source data verification (SDV) is a critical activity within clinical trial monitoring, yet the traditional approach focused on 100% SDV is limited in its ability to quickly identify issues and prevent them from recurring. Rave TSDV (Targeted SDV), unified with Rave EDC, enables CRAs to focus on critical to quality (CtQ) factors identified within risk management activities.
-
Quality Assurance
5/7/2024
A seasoned QA ally brings extensive local insights and expertise to navigate the intricate web of country-specific regulations.
-
Orphan And Rare Disease CRO Services
6/27/2023
There may be as many as 8,000 rare diseases, affecting between 6% and 8% of the worldwide population in total. It is estimated there are about 30 million affected people in the EU and in North America, while over 45 million people may be suffering from a rare condition in Asia, with 10 million people in China alone.
-
Client Insights: Why You Should Choose Kayentis As Your eCOA & DCT Provider
3/17/2023
Discover why 95.6% of Kayentis’ clients recommend Kayentis as eCOA and DCT provider in 2023.
-
Study Start-Up Shouldn’t Slow Your Trials Down
5/24/2023
Clinical teams are responsible for driving trial timelines during the study start-up phase of any study. Unearth how Florence SiteLink is able to create a digital link between teams and their sites.